Over 2,000 people prescribed HIV prevention drug since B.C. fully funded it, health minister says

Since the start of 2018, more than 2,000 people have been prescribed a potentially life-saving drug to prevent new HIV infections in B.C.

That’s according to B.C. Health Minister Adrian Dix, who says the province continues to lead the way in the global fight against the disease.

The cutting-edge strategies are called PrEP and PEP, or pre-exposure prophylaxis and post-exposure prophylaxis.

The province celebrated the six-month milestone since the province introduced no-cost coverage of PrEP and expanded assess to PEP for high-risk patients in a news conference Tuesday morning.

“Six months ago we launched a significant initiative… we didn’t do it with fanfare then because we wanted to show not tell what the impact of this policy could be,” Dix said.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search